Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuan-Chi Chiang

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JIMD Reports|June 22, 2016
Newborn Screening for Vitamin B<sub>6</sub> Non-responsive Classical Homocystinuria: Systematical Evaluation of a Two-Tier StrategyJürgen G Okun, Hongying Gan-Schreier, Tawfeq Ben-Omran, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 12, 2014
Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in TaiwanHsuan-Chieh Liao, Chuan-Chi Chiang, Dau-Ming Niu, et al.
Orphanet Journal of Rare Diseases|May 27, 2018
Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in TaiwanChih-Kuang Chuang, Hsiang-Yu Lin, Tuan-Jen Wang, et al.
Journal of the Chinese Medical Association : JCMA|January 7, 2014
Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfaHsiang-Yu Lin, Yu-Hsiu Huang, Hsuan-Chieh Liao, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese populationHsiang-Yu Lin, Kah-Wai Chong, Ju-Hui Hsu, et al.
BMJ Open|July 19, 2013
Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)Hsiang-Yu Lin, Hao-Chuan Liu, Yu-Hsiu Huang, et al.
Journal of the Chinese Medical Association : JCMA|July 7, 2010
Newborn screening for methylmalonic aciduria by tandem mass spectrometry: 7 years' experience from two centers in TaiwanKang-Hsiang Cheng, Mei-Ying Liu, Chuan-Hong Kao, et al.
Orphanet Journal of Rare Diseases|April 4, 2019
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groupsTzu-Hung Chu, Yin-Hsiu Chien, Hsiang-Yu Lin, et al.
Orphanet Journal of Rare Diseases|July 2, 2014
Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4 + 919G > A)Ting-Rong Hsu, Shih-Hsien Sung, Fu-Pang Chang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 24, 2013
Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)Hsuan-Chieh Liao, Yu-Hsiu Huang, Yann-Jang Chen, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JIMD Reports|June 22, 2016
Newborn Screening for Vitamin B<sub>6</sub> Non-responsive Classical Homocystinuria: Systematical Evaluation of a Two-Tier StrategyJürgen G Okun, Hongying Gan-Schreier, Tawfeq Ben-Omran, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 12, 2014
Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in TaiwanHsuan-Chieh Liao, Chuan-Chi Chiang, Dau-Ming Niu, et al.
Orphanet Journal of Rare Diseases|May 27, 2018
Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in TaiwanChih-Kuang Chuang, Hsiang-Yu Lin, Tuan-Jen Wang, et al.
Journal of the Chinese Medical Association : JCMA|January 7, 2014
Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfaHsiang-Yu Lin, Yu-Hsiu Huang, Hsuan-Chieh Liao, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese populationHsiang-Yu Lin, Kah-Wai Chong, Ju-Hui Hsu, et al.
BMJ Open|July 19, 2013
Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)Hsiang-Yu Lin, Hao-Chuan Liu, Yu-Hsiu Huang, et al.
Journal of the Chinese Medical Association : JCMA|July 7, 2010
Newborn screening for methylmalonic aciduria by tandem mass spectrometry: 7 years' experience from two centers in TaiwanKang-Hsiang Cheng, Mei-Ying Liu, Chuan-Hong Kao, et al.
Orphanet Journal of Rare Diseases|April 4, 2019
Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groupsTzu-Hung Chu, Yin-Hsiu Chien, Hsiang-Yu Lin, et al.
Orphanet Journal of Rare Diseases|July 2, 2014
Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4 + 919G > A)Ting-Rong Hsu, Shih-Hsien Sung, Fu-Pang Chang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 24, 2013
Plasma globotriaosylsphingosine (lysoGb3) could be a biomarker for Fabry disease with a Chinese hotspot late-onset mutation (IVS4+919G>A)Hsuan-Chieh Liao, Yu-Hsiu Huang, Yann-Jang Chen, et al.
Pageof 4